<html>
<head>PUBMED IDs for OPCM</head>
<body bgcolor='#C5F0F2'><h1>OPCM</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12819783/'>OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.</a> June 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16204069/'>CpG island methylation of DNA damage response genes in advanced ovarian cancer.</a> October 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16384911/'>RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.</a> December 31  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16733898/'>[Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].</a> June 1  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16762191/'>[*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].</a> June 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16764763/'>[Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].</a> June 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17159813/'>Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.</a> December 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17239010/'>Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.</a> January 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17564960/'>A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.</a> June 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18499731/'>Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.</a> May 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18584347/'>OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18584345/'>Induction of the human heat shock promoter HSP70B by nutritional stress: implications for cancer gene therapy.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18584344/'>HER2-positive breast cancer: current treatment strategies.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18714356/'>OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.</a> August 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20520618/'>Diagnosis and fine mapping of a deletion in distal 11q in two Chinese patients with developmental delay.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21255913/'>Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.</a> May 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21273058/'>Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.</a> November 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21273056/'>Genetic and cellular mechanisms of oncogenesis.</a> May 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21833655/'>OPCML gene as a schizophrenia susceptibility locus in Thai population.</a> September 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22585860/'>The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.</a> January 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23495067/'>An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.</a> September 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24327526/'>Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.</a> December 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24616287/'>Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects.</a> December 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24686180/'>Expression analysis of the genes identified in GWAS of the postmortem brain tissues from patients with schizophrenia.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25625843/'>Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.</a> July 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25652468/'>DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25966226/'>Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.</a> February 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26175934/'>OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling.</a> July 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26442469/'>Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.</a> August 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26442457/'>Monocyte enhancers are highly altered in systemic lupus erythematosus.</a> September 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26861414/'>Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns.</a> June 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26890304/'>Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.</a> May 24  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27358143/'>Effect of OPCML gene on the biological behavior of gastric cancer cell line AGS.</a> September 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27646854/'>Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.</a> September 21  2016<br></body></html>
